Moreover, we demonstrated that tumor-specific CD4+ T cells also became exhausted during tumor progression and that PD-L1 administration caused a proliferative burst of the tumor-specific CD4+ T cells, which could eliminate lung metastasis. This evidence concerns the gene CD4 and neoplasm.